Wednesday 6th April 2022 |
Text too small? |
Green Cross Health announces the appointment of Craig Brockliss to the Board, effective 6 April 2022. Mr Brockliss will stand for election at the Annual Shareholders’ Meeting currently scheduled to be held on 25 July 2022.
In accordance with Rule 2.6.1 of the NZX Listing Rules, the Board has determined that Mr Brockliss is a non-independent director due to a disqualifying relationship with substantial product holder Wilton Asset Management Limited, currently the third largest Green Cross Health shareholder.
Craig Brockliss is CEO of the Wilton Capital Group of companies and has more than 20 years’ experience in business, property and private equity investing. Wilton Capital has significant investment interests in both New Zealand, the United States and in the UK.
Wilton Capital has its origins in the pharmaceutical logistics markets in New Zealand and Australia before diversifying into other investments in 2001.
Craig holds a Bachelor of Commerce and a Bachelor of Laws from the University of Auckland and worked for Ernst and Young prior to joining the Wilton Group in 2001.
Kim Ellis
Chair
ENDS
No comments yet
BPG - Blackpearl Acquires US AI Platform to Accelerate Growth
TGG - Response to media speculation
ARB - Annual Meeting Date and Director Nominations
CNU - Q4 FY25 Connections Update
MOVE FY25 Results and Investor Briefing 29 August 2025
RYM - First quarter trading update
July 11th Morning Report
IKE Announces equity raising of A$20 million
Chorus full year results date
FPH 2025 Notice of Annual Meeting and Voting Form